Form 4: Establishment Labs Director Bryan Slotkin Receives Equity Award

Establishment Labs Holdings Inc. Director Bryan Slotkin was granted 3,413 common shares as a stock unit award, vesting in 2026.

Summary

• Bryan Slotkin, a Director of ESTABLISHMENT LABS HOLDINGS INC. (ESTA), was awarded 3,413 common shares.
• The transaction date for this acquisition was May 23, 2025.
• The shares were acquired at a price of $0, indicating a stock unit award rather than a purchase.
• Following this transaction, Bryan Slotkin beneficially owns 28,972 common shares directly.
• The award was made under the Issuer's 2018 Equity Incentive Plan.
• The shares are scheduled to vest in full on the earlier of May 23, 2026, or the day prior to the date of the Issuer's next annual meeting of stockholders.
• Vesting is contingent upon Mr. Slotkin continuing as a service provider through the vesting date.

Sentiment

Score: 7

Explanation: The sentiment is positive as a director receiving a stock award aligns their interests with shareholders and is a standard compensation practice, indicating stability in governance. There are no negative surprises or significant risks beyond typical equity holding.

Positives

• The stock unit award to Director Bryan Slotkin aligns his interests with those of the shareholders, incentivizing long-term performance.
• The award is part of the company's established 2018 Equity Incentive Plan, indicating a structured approach to executive and director compensation.

Negatives

• The award of new shares could result in minor dilution for existing shareholders, although the amount is relatively small in the context of total outstanding shares.

Risks

• The vesting of the awarded stock units is subject to Bryan Slotkin's continued service as a director until the vesting date, meaning the award is not guaranteed if service ceases.
• The ultimate value of the awarded shares is subject to market fluctuations of ESTABLISHMENT LABS HOLDINGS INC. common stock, posing a market risk to the recipient.

Future Outlook

The awarded stock units are set to vest in full on the earlier of May 23, 2026, or the day prior to the company's next annual meeting of stockholders, contingent on the director's continued service.

Management Comments

• The company awarded 3,413 stock units to Director Bryan Slotkin under its 2018 Equity Incentive Plan, reflecting a commitment to aligning director incentives with long-term shareholder value.

Industry Context

This Form 4 filing details a routine insider transaction related to director compensation, which is a common practice across publicly traded companies to incentivize and retain key personnel. It does not provide broader industry trends or competitive insights.

Comparison to Industry Standards

• The practice of granting equity awards to directors as part of their compensation is a standard corporate governance practice across various industries, including the medical technology sector where Establishment Labs operates.
• The use of a pre-existing equity incentive plan (2018 Equity Incentive Plan) is typical for established public companies to manage stock-based compensation.

Stakeholder Impact

• Shareholders: Potential minor dilution from the issuance of new shares, but also improved alignment of director interests with long-term company performance.
• Director (Bryan Slotkin): Receives additional equity compensation, increasing his stake and direct financial interest in the company's success.

Next Steps

• The awarded stock units will vest on the earlier of May 23, 2026, or the day prior to the Issuer's next annual meeting of stockholders, subject to continued service.

Key Dates

Keywords

Establishment Labs Holdings Inc., ESTA, SEC Form 4, Insider Transaction, Stock Award, Equity Incentive Plan, Director Compensation, Bryan Slotkin, Stock Units, Vesting